Company / Shares Outstanding
Nurix Therapeutics, Inc. Shares Outstanding History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
75.9M
FY2025
5-year range
38.9M / 75.9M
FY2021-FY2025
Trend
+55.7%
vs FY2024
Sector context
#124 of 212
Health Care
What the data says
At 75870718.00, Nurix Therapeutics, Inc.'s shares outstanding ranks #89 of 212 in the Health Care sector. Shares Outstanding has increased for 6 consecutive years, from 3292514.00 in FY2019 to 75870718.00 in FY2025.
Based on SEC 10-K filings.
75870718.00 in FY2025 with a 5-year CAGR of +84.0%.
Increased from 47172299.00 to 75870718.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +19.3%
- 5-Year CAGR
- +84.0%
- 10-Year CAGR
- -
Sector benchmark
#89 of 212 in Health CareTop 42% of 212This company 75.9M Sector average 306.0M
▼
-75.2% below sector average
Key checks
Key Insights
- Nurix Therapeutics, Inc.'s shares outstanding has grown for 6 consecutive years.
- In FY2025, shares outstanding increased 55.7% year-over-year.
- Ranks #124 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 75.9M | +55.7% |
| FY2024 | 48.7M | +3.3% |
| FY2023 | 47.2M | +5.6% |
| FY2022 | 44.7M | +14.9% |
| FY2021 | 38.9M | +981.0% |
| FY2020 | 3.6M | +9.2% |
| FY2019 | 3.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026